Previous 10 | Next 10 |
Zynex (ZYXI): Q1 GAAP EPS of -$0.02 beats by $0.01.Revenue of $24.1M (+58.2% Y/Y) beats by $0.43M.Outlook: The estimated range for second quarter revenue is between $31.0 and $32.5 million with Adjusted EBITDA between $3.0 and $4.0 million. The revenue estimate is approximately 61% to 69% abo...
Zynex Announces 2021 First Quarter Earnings PR Newswire ENGLEWOOD, Colo. , April 29, 2021 /PRNewswire/ -- 2021 First Quarter Revenue increased 58% year over year to $24.1 million Orders increased 140% Net loss of ...
Zynex Appoints Donald Gregg as Vice President of Sales and Operations of Monitoring Solutions Division PR Newswire ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manuf...
Zynex Schedules 2021 First Quarter Earnings Call PR Newswire ENGLEWOOD, Colo., April 19, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI) , an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices f...
Zynex is well positioned to capitalize on recent fundamental momentum in sales volume and top-line growth. Such momentum hasn't yet translated to share performance, and the market continues to discount Zynex shares. Questions around management's posture on inventory remain, and la...
Zynex ([[ZYXI]] -3.5%) announces Q1 order growth of 140% Y/Y, and confirms its previous revenue estimate 1Q21 of between $23M and $24.5M vs. consensus of $23.8M and Adj. EBITDA loss estimate of between $0.5M and $1.5M.FY21 revenue estimate is between $135M and $150M vs. consensus of $138.03M;...
Zynex Announces 140% Year over Year Order Growth in Q1-2021 PR Newswire ENGLEWOOD, Colo. , April 12, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devi...
Zynex Growth Leads to New Corporate Headquarters PR Newswire ENGLEWOOD, Colo. , April 9, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa...
Zynex Recognized as the Sixth Largest Biotechnology/Bioscience Company in Colorado PR Newswire ENGLEWOOD, Colo., March 30, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of n...
Zynex ([[ZYXI]] +4.4%) says it has received board approval to repurchase $10M of shares through expiry of Sep. 8, 2021."We believe that the current market value of our shares does not accurately reflect the underlying value of the Company and the buyback program represents an attractive oppor...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...